249 related articles for article (PubMed ID: 27334757)
21. ATR activated by EB virus facilitates chemotherapy resistance to cisplatin or 5-fluorouracil in human nasopharyngeal carcinoma.
Zhang B; Cui B; Du J; Shen X; Wang K; Chen J; Xiao L; Sun C; Li Y
Cancer Manag Res; 2019; 11():573-585. PubMed ID: 30666155
[TBL] [Abstract][Full Text] [Related]
22. Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1.
Yin P; Song G; Jiang Z
Cancer Chemother Pharmacol; 2018 May; 81(5):863-872. PubMed ID: 29536130
[TBL] [Abstract][Full Text] [Related]
23. NFBD1/MDC1 stabilizes oncogenic MDM2 to contribute to cell fate determination in response to DNA damage.
Inoue K; Nakanjishi M; Kikuchi H; Yamamoto H; Todo S; Nakagawara A; Ozaki T
Biochem Biophys Res Commun; 2008 Jul; 371(4):829-33. PubMed ID: 18471438
[TBL] [Abstract][Full Text] [Related]
24. TRIM24 siRNA induced cell apoptosis and reduced cell viability in human nasopharyngeal carcinoma cells.
Wang P; Shen N; Liu D; Ning X; Wu D; Huang X
Mol Med Rep; 2018 Jul; 18(1):369-376. PubMed ID: 29749443
[TBL] [Abstract][Full Text] [Related]
25. URG4-silencing suppresses cell proliferation in nasopharyngeal carcinoma through induction of apoptosis.
Luo XY; Yan B; Cai CF; Chen AM; Zhou M
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1717-1725. PubMed ID: 29630117
[TBL] [Abstract][Full Text] [Related]
26. Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.
Huang PY; Zeng TT; Ban X; Li MQ; Zhang BZ; Zhu YH; Hua WF; Mai HQ; Zhang L; Guan XY; Li Y
BMC Cancer; 2016 Aug; 16(1):669. PubMed ID: 27549330
[TBL] [Abstract][Full Text] [Related]
27. Identification Keratin 1 as a cDDP-resistant protein in nasopharyngeal carcinoma cell lines.
Tang S; Huang W; Zhong M; Yin L; Jiang H; Hou S; Gan P; Yuan Y
J Proteomics; 2012 Apr; 75(8):2352-60. PubMed ID: 22348822
[TBL] [Abstract][Full Text] [Related]
28. Reversal of cisplatin sensitization and abrogation of cisplatin-enriched cancer stem cells in 5-8F nasopharyngeal carcinoma cell line through a suppression of Wnt/β-catenin-signaling pathway.
Sinnung S; Janvilisri T; Kiatwuthinon P
Mol Cell Biochem; 2021 Apr; 476(4):1663-1672. PubMed ID: 33423190
[TBL] [Abstract][Full Text] [Related]
29. NFBD1/MDC1 is phosphorylated by PLK1 and controls G2/M transition through the regulation of a TOPOIIα-mediated decatenation checkpoint.
Ando K; Ozaki T; Hirota T; Nakagawara A
PLoS One; 2013; 8(12):e82744. PubMed ID: 24349352
[TBL] [Abstract][Full Text] [Related]
30. Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells.
Li S; Zhang X; Zhang R; Liang Z; Liao W; Du Z; Gao C; Liu F; Fan Y; Hong H
Cell Cycle; 2017; 16(17):1601-1610. PubMed ID: 28749195
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma.
Man CH; Wei-Man Lun S; Wai-Ying Hui J; To KF; Choy KW; Wing-Hung Chan A; Chow C; Tin-Yun Chung G; Tsao SW; Tak-Chun Yip T; Busson P; Lo KW
J Pathol; 2012 Feb; 226(3):471-81. PubMed ID: 22009689
[TBL] [Abstract][Full Text] [Related]
32. Exosomes derived from Taxol-resistant nasopharyngeal carcinoma (NPC) cells transferred DDX53 to NPC cells and promoted cancer resistance to Taxol.
Yuan F; Zhou ZF
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):127-138. PubMed ID: 33506900
[TBL] [Abstract][Full Text] [Related]
33. LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer.
Wang S; Zou Z; Luo X; Mi Y; Chang H; Xing D
Oncogene; 2018 Jun; 37(24):3243-3259. PubMed ID: 29545602
[TBL] [Abstract][Full Text] [Related]
34. The Homologous Recombination Repair Pathway is Associated with Resistance to Radiotherapy in Nasopharyngeal Carcinoma.
Wang Z; Zuo W; Zeng Q; Li Y; Lu T; Bu Y; Hu G
Int J Biol Sci; 2020; 16(3):408-419. PubMed ID: 32015678
[TBL] [Abstract][Full Text] [Related]
35. Growth inhibition, morphology change, and cell cycle alterations in NFBD1-depleted human esophageal cancer cells.
Yang Z; Bu Y; Wang C; Liu G; Song F
Mol Cell Biochem; 2010 Sep; 342(1-2):1-6. PubMed ID: 20364298
[TBL] [Abstract][Full Text] [Related]
36. BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer.
Kuang CM; Fu X; Hua YJ; Shuai WD; Ye ZH; Li Y; Peng QH; Li YZ; Chen S; Qian CN; Huang W; Liu RY
Cell Death Dis; 2017 Jun; 8(6):e2874. PubMed ID: 28617432
[TBL] [Abstract][Full Text] [Related]
37. Comparative Proteomic Profiling of Cisplatin-resistant Nasopharyngeal Carcinoma Cell Lines: Novel Biomarkers for Improving Chemotherapy of NPC.
Prathaphan P; Reamtong O; Ngaokrajang U; Janvilisri T; Swainson NM; Kiatwuthinon P
Anticancer Res; 2022 Jul; 42(7):3507-3522. PubMed ID: 35790268
[TBL] [Abstract][Full Text] [Related]
38. Blockage of SSRP1/Ets-1/Pim-3 signalling enhances chemosensitivity of nasopharyngeal carcinoma to docetaxel in vitro.
Ai J; Li W; Zeng R; Xie Z; Liu H; Hou M; Tan G
Biomed Pharmacother; 2016 Oct; 83():1022-1031. PubMed ID: 27525970
[TBL] [Abstract][Full Text] [Related]
39. 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage.
Mochan TA; Venere M; DiTullio RA; Halazonetis TD
Cancer Res; 2003 Dec; 63(24):8586-91. PubMed ID: 14695167
[TBL] [Abstract][Full Text] [Related]
40. STAT5a-targeting miRNA enhances chemosensitivity to cisplatin and 5-fluorouracil in human colorectal cancer cells.
Hong X; Chen G; Wang M; Lou C; Mao Y; Li Z; Zhang Y
Mol Med Rep; 2012 May; 5(5):1215-9. PubMed ID: 22367509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
